Tuesday, March 1, 2011
BrainStorm Cell Therapeutics Inc., of New York, said it raised about $3.6 million from the sale of 12.8 million shares at 28 cents per share in a private placement financing. The company also said it issued warrants to the investors, with exercise prices of 28 cents and 50 cents per share, with expiration dates of one year and two years, respectively.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.